NR4A1 and breast carcinoma: Wang et al. found in cellular experiments that fructose-2,6-bisphosphatase 4 promotes glycolysis, enhances cellular stemness, and triggers metabolic reprogramming, making hormone receptor-positive breast cancer cells resistant to palbociclib.36